Our clinical phase I/IIa trial with FOL-005 was completed at the beginning of 2017, and showed a good safety of the treatment. The results also showed a clear stimulation of hair growth that was statistically significant. See FOL-005. The trials were carried out at the Clinical Research Centre (CRC) of the Charité University Hospital in Berlin.
In parallel with our development of FOL-005 we continue the pre-clinical trials with other peptides, among these FOL-014, which early on showed an increased release of insulin from the pancreas in in-vitro studies.
The Diabetes Research Group led by Professor Jan Nilsson at the Clinical Research Centre of Lund University receives a substantial financing from the Novo Nordisk Foundation to widen the pre-clinical research on diabetes with the Follicum peptides.
During spring 2017 Follicum was invited to become a partner in a very comprehensive research project with the University of Lund in diabetes research. This project has received a considerable funding of up to 100 MSEK from the Swedish Foundation for Strategic Research. Read more: (Only in Swedish) Research cooperations.
Follicum is also actively pursuing different projects for the formulation of the treatment with FOL-005, ointments, cream, powder and other preparation, preparing for up-coming clinical trials.